脱发90后撑起一个IPO,公司年赚近4亿,毛利率超82%
2 1 Shi Ji Jing Ji Bao Dao·2025-11-25 12:07

Core Viewpoint - The IPO application of Mandi Inc., a subsidiary of Sihuan Pharmaceutical, aims to become the first listed company in China's hair health sector, capitalizing on a market with over 339 million people suffering from hair loss and a projected market growth rate of 11.3% annually [1][3][5]. Market Demand and Growth - The hair health management market in China is expected to exceed 80 billion yuan in 2024, with a compound annual growth rate (CAGR) of 11.3% projected from 2024 to 2035, potentially reaching 171.4 billion yuan by 2035 [3][5]. - The demographic of hair loss sufferers is predominantly under 35 years old, accounting for over 60% of the total, indicating a shift from optional to essential consumption in this market [3][5]. Company Performance and Product Portfolio - Mandi Inc. has established a strong market presence, with its core product series, the Mandi® series, holding over 71% market share in the minoxidil drug market as of 2024 [5][6]. - The company reported revenue growth from 982 million yuan in 2022 to 1.455 billion yuan in 2024, with a net profit increase from 202 million yuan to 390 million yuan during the same period, reflecting a CAGR of 21.7% [6][8]. Challenges and Risks - Mandi Inc. faces significant risks due to its high dependency on core products, with 92.4% of its revenue in the first half of 2025 coming from the Mandi series [8][9]. - The company has low R&D investment, with only 2.62% of revenue allocated to R&D in the first half of 2025, raising concerns about its long-term competitiveness [9]. - Supply chain concentration is a risk, with the top five suppliers accounting for 75.6% of procurement, making the company vulnerable to supply disruptions [9]. Strategic Plans and Future Outlook - The IPO proceeds will be used to enhance R&D, expand product lines, and optimize the supply chain, focusing on women's hair loss treatments and new topical formulations [10][11]. - The company aims to balance short-term sales with long-term R&D investments to build sustainable growth and reduce reliance on the Mandi series [11]. - The competitive landscape is evolving, with traditional and emerging brands entering the market, necessitating Mandi Inc. to innovate and adapt to maintain its market position [9][11].

脱发90后撑起一个IPO,公司年赚近4亿,毛利率超82% - Reportify